initi outperform pt
alway winner start gate
portfolio transform becom evid nt headwind abat
bullish share time mark
expect turn point core growth recent acquisit anniversari
portfolio transform took hold underli dynam
thesi take hold perform somewhat mask
challeng dental busi surpris deceler
pall key segment enter contend sever
headwind resolv expect improv
perform even across dental segment balanc
pall see recoveri bioprocess demand inventori de-
stock appear complet industri benefit macro
factor well pass tough comp respect dental
see slow steadi recoveri channel issu resolv
underli weak basic consum start comp
macro benefit cphd bia core veli pick
turn key segment see stabl improv growth
cite strong macro outlook core momentum includ
cphd core upwardli bia dx furthermor expectedli
quiet anticip pace pick-up balanc
sheet return flexibl level albeit caution public valuat
elev valuat front multipl certainli
inexpens see sustain tradit rel premium
believ may even re-expand see core acceler given
dynam see risk reward favor thu initi share
o/p rate
thing watch trajectori global pmi dental trend
share commentari activ
see bottom dental recoveri viabl
lt outlook pall chang mix
valuat price target base dcf methodolog
contempl wacc termin ebitda multipl
equat perpetu growth rate pt
translat ebitda vs average
price-to-earnings basi translat vs average
downsid risk potenti continu pressur across
dental channel given chang distributor relationship overal
mute volum slowdown china relat demand given shift
govern polici materi depress key geograph driver core
growth biosimilar uncertainti yield continu inventori work
pall result anoth year average revenu momentum
modest ep upsid capit alloc dx revenu stagnat
tough flu comp limit volum growth challeng strong
cphd perform limit bec municip budget face
demand constrain core rate
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
initi outperform pt
alway winner start gate
last page report import disclosur regard stock report
tabl content
debat see bottom dental recoveri viabl
debat lt outlook pll chang mix
point differenti vs st
iv valuat risk dental challeng abat
 conclus initi o/p growth mean revers
portfolio undergon complet transform
global famili greater oper compani
focus life scienc dental diagnost
thesi growth recov post challeng pll
dental recent synergi build
b/ prime capit deploy
rate valuat pt outperform pt
ebitda vs average
price-to-earnings vs average
risk continu growth challeng dental unit
rich valuat stymi capit alloc cadenc
deep bench w/ db secret sauc across divis
debat recent reshap core margin profil lt
strateg spin transform industri scienc tech centric conglomer
spun bn industri revenu
 shift product mix toward consum
debat recent reshap core margin profil lt
db playbook strong histori improv core growth drive bp omx annual
current rev compani own yr
revenu
revenu
core/omx like
acceler given
average age portfolio today yr
debat see bottom dental recoveri viabl
dental u/p dental market rest
dig deeper segment tale citi
challeng face tradit consum busi
overshadow improv made nobel
db drove solid improv busi nobel
manag treat entir dental like new
acquisit appli db aggress
brand/opco consolid took opco
increas
manag feel begin see fruit db
platform grow lsd/msd
indirect imag equip etc kavo lsd
china post dd growth consist mt
particularli us bit eu dental
us distributor de-stock issu continu period rear
head last seen earli
channel disrupt due break exclus w/
siro/xray open cad/cam market
bottom
recov lt
debat lt outlook pll chang mix
hw macro tough comp hurrican
industri tough comp larg mid east project
industri middl east comp overal macro still
comp pll life scienc deceler
life dd singl use signific hw
hurrican week shut puerto rico de-
stock bioprocess custom
investor wari bioprocess slowdown
bioprocess slow due sever key account de-
base pipelin expect increas demand
stock better manag inventori
base peer commentari investor concern someth
structur could play given biopharma strong growth
last coupl year
larger biopharma custom de-stock like impact
compound tough dd comp past sever
bioproduct lumpi businesssaw custom
manag inventori
bioprocess msd see larg key account de-
stock clear idea stop merck kgaa
biolog biosimilar vaccin enter market
single-us technolog continu growth driver dd
view growth challeng tempor see acceler beyond
model summari point differenti vs street
swing factor dental trajectori pace pll recoveri cadenc capit alloc
point differenti
revenu st
year core
synergi ramp
ep st w/
capit alloc
leverag remain
manag level
like prove activ mid-siz drive ep upsid
million except per share data fy end decemb appli organ organ organ organ organ gp less total appli op less ep share inc net inc price-to-earnings prem disc januari
rel valu appeal basi improv
near-term valuat elev ebitda metric appear compel rel price-to-earnings
risk point favor risk reward profil delay dental growth re-norm vs pll acceler
potenti continu pressur across dental channel given chang distributor relationship overal mute volum
slowdown china relat demand given shift govern polici materi depress key geograph driver core growth
biosimilar uncertainti yield continu inventori work pall result anoth year average revenu momentum
elev valuat multipl rise rate depress activ result modest ep upsid capit alloc
dx revenu stagnat tough flu comp limit volum growth challeng strong cphd perform limit bec
municip budget face challeng given increas global polici uncertainti pressur water demand constrain core rate
dcf valuat yield price
dcf deriv pt impli termin growth rate impli ebitda multipl
assumpt underli dcf valuat methodolog
year ebita margin assumpt
termin ebitda multipl
tax rate
wacc base beta risk free rate cost debt
assumpt impli termin growth rate
discount ebitda termin free flow enterpris total valu valu per perpetu growth valu enterpris enterpris valu januari
conclus initi outperform pt upsid
bullish share time mark expect turn point
core growth recent acquisit anniversari portfolio transform took hold
underli dynam thesi take hold perform somewhat mask
challeng dental busi surpris deceler pall key segment
enter contend sever headwind resolv
expect improv perform even across dental segment balanc
pall see recoveri bioprocess demand inventori de-stock appear complet
industri benefit macro factor well pass tough comp
respect dental see slow steadi recoveri channel issu resolv
underli weak basic consum start comp remain bullish lt
turn key segment see stabl improv growth cite strong macro
outlook core momentum includ cphd core upwardli bia dx
furthermor expectedli quiet anticip pace pick-up
balanc sheet return flexibl level albeit caution public valuat elev
valuat front multipl certainli inexpens see sustain
tradit rel premium believ may even re-expand see core acceler
given dynam see risk reward favor thu initi share o/p rate
thing watch global pmi dental trend share commentari activ
pleas feel free reach question follow-up
medic suppli devic
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin januari et
analyst ross muken vijay kumar luke sergott primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research
